Tel: 407.377.PARK (7275)
Email: Info [@] 50Park.com
Tel: 407.377.PARK (7275)
Email: Info [@] 50Park.com
50 Park Investments 50 Park Investments
  • Home
  • Webinars
  • Contact
    • Contact Information
    • Schedule an Appointment With Our CEO
    • Privacy Policy
    • Disclaimer
    • TOS
50 Park Investments 50 Park Investments
Menu
Home » Posts Tagged "Study Identifies Heart Risks in Glaxo’s Avandia"
22 Feb
Video

Study Identifies Heart Risks in Glaxo's Avandia

  • February 22, 2010
  • By author-avatar info@50park.com
  • 0 comments

Airtime: Mon. Feb. 22 2010 | ET
Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.

© 50 Park Investments - You Deserve The Personal Touch ℠
Privacy Policy | Disclaimer
  • Home
  • Webinars
  • Contact
    • Contact Information
    • Schedule an Appointment With Our CEO
    • Privacy Policy
    • Disclaimer
    • TOS
Start typing to see posts you are looking for.